Biomet Opts For $13.4B Sale To Zimmer, Halts IPO Plans
Private equity-backed Biomet Inc. said Thursday it would trade hands in a $13.4 billion sale to medical device maker Zimmer Holdings Inc., effectively scrapping the orthopedic product firm's initial public offering...To view the full article, register now.
Already a subscriber? Click here to view full article